Sustains volume trajectory; miss on margin

Company

28 Oct 2024 | 5 Min Read

Colgate's financials and valuations show steady growth in sales and EBITDA.

The company's volume growth has been in line with expectations.

Gross margin and EBITDA margin contracted, impacting overall performance.

The stock has witnessed a sharp re-rating in the last 12-15 months.

The current valuation at 58x/53x P/E on FY25E/FY26E captures most near-term triggers.

The company's historical volume growth has been weaker than its peers.